Revenue
2019
2020
2021
2022
2023
2024
2025
BIODESIX INC (BDSX)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $88.5M | $71.3M | $49.1M | $38.2M | $54.5M | $45.6M | $24.6M |
| Research & development | $12.0M | $9.6M | $10.0M | $13.1M | $12.8M | $10.8M | $10.5M |
| Operating expenses | $116.4M | $105.8M | $90.4M | $88.8M | $95.4M | $68.5M | $51.3M |
| Operating income | −$27.9M | −$34.5M | −$41.3M | −$50.6M | −$40.9M | −$22.9M | −$26.7M |
| EBITDAderived | −$22.2M | −$28.7M | −$38.0M | −$47.0M | −$37.8M | −$20.0M | −$23.9M |
| Net income | −$35.3M | −$42.9M | −$52.1M | −$65.4M | −$43.2M | −$65.4M | −$30.7M |
| Basic EPSper diluted share | -$4.67 | -$6.64 | -$0.64 | -$1.55 | -$1.58 | -$6.48 | -$126.97 |
| Diluted EPSper diluted share | -$4.67 | -$6.64 | -$0.64 | -$1.55 | -$1.58 | -$6.48 | -$126.97 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 23, 2026Form 4 | Vazquez ChrisChief Accounting Officer | SellCommon Stock | 211 | $12.78 | $2.7K | 1.6K |
| Feb 23, 2026Form 4 | Cowie Robin HarperCFO, Sec'y & Treasurer | SellCommon Stock | 535 | $12.78 | $6.8K | 16.2K |
| Feb 23, 2026Form 4 | Hutton ScottPresident & CEO | SellCommon Stock | 1.5K | $12.78 | $19.0K | 48.8K |
| Feb 23, 2026Form 4 | Pestano Gary AnthonyChief Development Officer | SellCommon Stock | 556 | $12.78 | $7.1K | 10.4K |
| Feb 23, 2026Form 4 | O'Kane KieranChief Commercial Officer | SellCommon Stock | 535 | $12.78 | $6.8K | 9.8K |